Gina Kolata

1 week ago | irishtimes.com | Gina Kolata

A group of 97 patients had long-standing multiple myeloma, a common blood cancer that doctors consider incurable, and faced a certain, and extremely painful, death within about a year. They had gone through a series of treatments, each of which controlled their disease for a while. But then it came back. They reached the stage where they had no more options and were facing hospice care. They all got immunotherapy, in a study that was a last-ditch effort.

2 weeks ago | sandiegouniontribune.com | Gina Kolata

By Gina KolataThe New York TimesBreast cancer patients whose tumors have spread to other parts of their bodies live from scan to scan. Is their treatment working? Or will they learn their cancer is growing again? But a new study sponsored by the drug company AstraZeneca showed that there is an alternative: Instead of waiting for a scan to show that a cancer is growing, it’s possible to find early signs that the cancer is resisting the drugs that were controlling it.

2 weeks ago | afr.com | Gina Kolata

Jun 10, 2025 – 7.20am or Subscribe to save articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe. Subscribe nowAlready a subscriber? A group of 97 patients had long-standing multiple myeloma, a common blood cancer that doctors consider incurable, and faced a certain, and extremely painful, death within about a year. They had gone through a series of treatments, each of which controlled their disease for a while.

2 weeks ago | elnorte.com | Gina Kolata

05 MIN 00 SEGGina Kolata / The NYT News ServicesMonterrey, México (09 junio 2025) .-05:00 hrsEl mieloma múltiple se considera incurable, pero un tercio de pacientes de un ensayo clínico ha vivido años sin cáncer detectable tras enfrentarse a una muerte segura Crédito: FreepikHabían pasado por una serie de tratamientos, cada uno de los cuales controló su enfermedad durante un tiempo. Pero ésta luego reapareció, como siempre ocurre.

3 weeks ago | lanacion.com.ar | Gina Kolata

NUEVA YORK.— Habían pasado por una serie de tratamientos, cada uno de los cuales controló su enfermedad durante un tiempo. Pero esta luego reapareció, como siempre ocurre. Llegaron a un punto en el que ya no tenían más opciones y lo único que les quedaba eran cuidados paliativos. Todos recibieron inmunoterapia como parte de un estudio que era un último esfuerzo. Una tercera parte respondió tan bien que obtuvo lo que parece ser un alivio asombroso.